Syngene International
SYNGENE · Pharma > Pharmaceuticals & Drugs · Chairman: Kiran Mazumdar Shaw · MD: Jonathan Hunt · Listing date: Aug. 11, 2015 · Employees: 5437 · Bangalore · http://www.syngeneintl.com

Stock Price vs Company Growth
1d
1.2%
1w
1.3%
1m
13.1%
3m
24.5%
6m
16.2%
1y
5.1%
5y
17.8%
all
17.1%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec14Dec16Dec18Dec20Dec22Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

692 1.2%
678
960
Company Overview

Sales
3,541 Cr
Growth: 1.7%
Profit after Tax
470 Cr
Growth: 4.4%
Mid Cap
27,848 Cr
P/E: 55.5x
Industry P/E: 29.7x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 3,541
Growth 1.7%
EBITDA 28.5%
P/S 7.9x
Dividend 0.1%
P/E 55.5x
Book Value ₹ 113
PEG Ratio 32.6x
ROE 10.7%
P/B 6.1x
Shareholding Pattern

Institutions
Government Pension Fund Global
1.14 %
Uti-Mid Cap Fund
1.03 %
Qualified Institutional Buyer
0.15 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Sep21Dec21Mar22Jun22Mar23Sep23Dec23Mar24Jun24Sep24Dec24
Promoters
Biocon Limited
70.1 %
Biocon Limited Employee Welfare Trust (Murali Krishnan K N And Amitava Saha)
0.32 %
Yamini R Mazumdar
0.01 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Sep21Dec21Mar22Jun22Mar23Sep23Dec23Mar24Jun24Sep24Dec24
Others
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Sep21Dec21Mar22Jun22Mar23Sep23Dec23Mar24Jun24Sep24Dec24
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide.
Investors (435)
Followers (14)